Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial. - Wikidata - awgldk - TriplyDB

Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial.

Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial.

http://www.wikidata.org/entity/Q44312443

about

Interventions for actinic keratoses Nonsurgical innovations in the treatment of nonmelanoma skin cancer Review of photodynamic therapy in actinic keratosis and basal cell carcinoma Topical PDT in the Treatment of Benign Skin Diseases: Principles and New Applications Photodynamic Therapy for Non-Melanoma Skin Cancers Pharmacotherapy of actinic keratosis.The role of light in the treatment of non-melanoma skin cancer using methyl aminolevulinate.Daylight PDT with MAL - current data and practical recommendations of an expert panel.Photodynamic therapy for actinic keratoses: survey of patient perceptions of treatment satisfaction and outcomes.Non-surgical treatments of primary, non-melanoma eyelid malignancies: a review.Therapeutic and aesthetic uses of photodynamic therapy part one of a five-part series: the use of photodynamic therapy in the treatment of actinic keratoses and in photorejuvenation.Actinic keratosis: rationale and management Therapeutic and Aesthetic Uses of Photodynamic Therapy Part three of a five-part series: Chemoprevention Utilizing ALA-PDT Comparative Study of Photodynamic Therapy with Topical Methyl Aminolevulinate versus 5-Aminolevulinic Acid for Facial Actinic Keratosis with Long-Term Follow-Up.Intensified photodynamic therapy of actinic keratoses with fractional CO2 laser: a randomized clinical trial.Network meta-analysis of the outcome 'participant complete clearance' in nonimmunosuppressed participants of eight interventions for actinic keratosis: a follow-up on a Cochrane review.Pharmacotherapy of actinic keratosis: an update.Multicentre intraindividual randomized trial of topical methyl aminolaevulinate-photodynamic therapy vs. cryotherapy for multiple actinic keratoses on the extremities.Efficacy of krypton laser photodynamic therapy for oral mucosa dysplasia in 9,10-dimethyl-1,2-benzanthracene-treated hamsters.Fractional erbium: YAG laser-assisted photodynamic therapy for facial actinic keratoses: a randomized, comparative, prospective study.Management of actinic keratosis: a practical report and treatment algorithm from AKTeam™ expert clinicians.Photodynamic therapy of cancer: an update Current treatment patterns in non-melanoma skin cancer across Europe.Clinical efficacy of methyl aminolevulinate (Metvix) photodynamic therapy.Methyl aminolevulinate (Metvix) photodynamic therapy - practical pearls.Cost-utility of first-line actinic keratosis treatments in Finland Methods and Results Report - Evidence and consensus-based (S3) Guidelines for the Treatment of Actinic Keratosis -International League of Dermatological Societies in cooperation with the European Dermatology Forum.Topical photodynamic therapy in clinical dermatology.Vitamin D3 enhances the apoptotic response of epithelial tumors to aminolevulinate-based photodynamic therapy.Photodynamic therapy in dermatology--an update.Noninvasive Optical Imaging of UV-Induced Squamous Cell Carcinoma in Murine Skin: Studies of Early Tumor Development and Vitamin D Enhancement of Protoporphyrin IX Production Photodynamic therapy in dermatology: current concepts in the treatment of skin cancer.5-Aminolevulinic acid derivatives in photomedicine: Characteristics, application and perspectives.The role of ingenol mebutate in the treatment of actinic keratoses.Aminolevulinic acid photodynamic therapy: medical evidence for its expanded use.Vitamin D Combined with Aminolevulinate (ALA)-Mediated Photodynamic Therapy (PDT) for Human Psoriasis: A Proof-of-Principle Study.Photodynamic therapy with methylaminolevulinate as a valuable treatment option for unilesional cutaneous T-cell lymphoma.Quantitative approach to skin field cancerization using a nanoencapsulated photodynamic therapy agent: a pilot study Treatment of post-transplant premalignant skin disease: a randomized intrapatient comparative study of 5-fluorouracil cream and topical photodynamic therapy.Photodynamic therapy: update 2006. Part 2: Clinical results.

P2860

Q24202407-C6978243-A5EB-4B24-9B40-48DACF00E53E Q24632006-B14E21F2-47F0-48B7-B73D-E6D3D105DC0B Q24647450-E9E1635B-7158-4977-AB44-6FF8A3D41FD0 Q26781377-A370489E-25FA-4BD2-A89C-B5FAE0642DCF Q28077445-EB6F5AEF-AD41-44AE-B506-11DFFFD2DD40 Q30898080-BE697004-E0A6-49EF-A2BE-05A2EA56E4E5 Q31004906-F167FE91-9DF0-4060-99C6-D5AB0CD0ADAF Q31028764-E834ACDA-6AD5-45AB-B040-1A4D78A2431B Q33345415-489560A9-F7AA-4012-B1DD-654655043BEF Q33735219-5A10DE47-6979-4023-9709-4241D7AC0004 Q33754505-B7B100CF-10C7-43AE-B932-6455920CDE30 Q33785049-6E154DDE-6089-4BFC-A254-D29C2B1DDC6C Q33787952-85F44CF3-1C92-4282-9006-CBC75BE9438B Q33801978-7D6E81A5-2FB0-4E17-9778-26A57DE11DAB Q34164028-E4D3E20F-7D8F-4FBF-AB7E-6852F1616489 Q34336675-8C249A08-AB35-419D-8249-59C9427158C2 Q34378153-A8D3B304-A3B5-4D13-95E1-3F4E417D77BC Q34761817-B8493050-F84D-44CC-AA93-E0896148EA1D Q35030136-ED138162-02D1-48EC-91EC-28A9B7258B5B Q35068206-391936A1-4DA9-4317-89C6-F54F9AE12618 Q35115492-1285609B-BD1E-4C78-9F5F-23315F900F98 Q35532394-8E6751EC-57AA-4FAE-ABD3-7DF66577459F Q35548847-4E02E599-876B-49AE-BE08-B0D138A74F6F Q35548851-AB0D7574-37CD-4060-A5F7-36EA9E2ED734 Q35548854-4A1700E3-05C4-4849-8561-44F72A1BB5D5 Q35666250-DB5841A6-D307-49BA-95A9-668A757F5714 Q35767304-F7A32154-3DC3-4BA5-AD3F-FE078621FD24 Q35815973-1872BC52-094C-40CB-B83E-F58C33EC871C Q35988610-13DFF892-2CFB-4519-BE29-51D6BFF81CEA Q36124185-42F63122-9791-4FDF-A912-605DDF139642 Q36244912-5176309E-2DF5-4D58-908B-44FE2EFD9D76 Q36284494-B23ADEC7-078D-417E-8A58-7C5018EEB97C Q36423131-00E3FAB5-7C7C-4A62-8118-AB48131655FC Q36434826-0E112589-1F03-40A0-8132-7E7BEEBD16A8 Q36471556-D93DC4C5-5F10-437A-B2EC-91B901D86B35 Q36477161-2D1599F7-1742-440A-AB87-8F4DA0C314BD Q36583835-F2D5256A-633D-405A-BAFD-75E85C93886C Q36635556-D81F412C-578A-4A37-B20A-9B1C95118DDE Q36711033-2B59AC51-6E94-4B66-A35E-2D51981471F0 Q36764960-19C2BD7D-5282-48CF-9A40-E9A961A49E70

P2860

Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial.

http://www.wikidata.org/entity/Q44312443

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh

2003年學術文章

@zh-hant

name

Photodynamic therapy with topi ...... randomized multicenter trial.

@en

Photodynamic therapy with topi ...... randomized multicenter trial.

@nl

type

label

Photodynamic therapy with topi ...... randomized multicenter trial.

@en

Photodynamic therapy with topi ...... randomized multicenter trial.

@nl

prefLabel

Photodynamic therapy with topi ...... randomized multicenter trial.

@en

Photodynamic therapy with topi ...... randomized multicenter trial.

@nl

P1433

Q44312443-BD532AEB-0541-4F6B-9D4A-6B1B9118A8F2

P1476

Q44312443-41B0F66C-A0E2-4D47-8F0B-7C744302EB60

P2093

Q44312443-140032EE-F91C-4C81-A2AB-380DB9D5704D

Q44312443-43AAEFEC-6D6E-4CA0-AAD0-F2B71997915F

Q44312443-4FBB2BA7-76AA-4807-AE9E-78D46004BEF7

Q44312443-84CA8AFD-8C88-4DE0-9578-A7A19776866F

Q44312443-8997DCDD-BC58-4EDB-B05D-846640D170B6

Q44312443-8BCBA487-AA26-4190-9DF5-64815F665B7F

Q44312443-FC5E1C7E-8B32-4A28-9DC7-04D0EA4122EA

P304

Q44312443-27D3AA3B-1E70-4E21-8E2E-B63D2B819F69

P31

Q44312443-4B976EA7-07A6-4DEE-A06C-051B6C455984

P356

Q44312443-E6308BF5-877B-44E8-8249-3CAF72C7995B

P407

Q44312443-EFEC7A5E-886E-42FA-9F1E-1B3F80416B08

P433

Q44312443-CE8C54C4-62A6-4DC7-BDF4-6E50DA4D0EAB

P478

Q44312443-BA5834EF-4E3C-4E8E-A57F-CC616783B6E3

P577

Q44312443-37C197BC-A8E3-41F3-84B5-F2D18B073D81

P698

Q44312443-324F45BA-116A-4A58-9F92-1426D01C9E38

P356

P1433

Journal of the American Academy of Dermatology

P1476

Photodynamic therapy with topi ...... randomized multicenter trial.

@en

P2093

Anne W Lucky

http://www.w3.org/2001/XMLSchema#string

Daniel M Stewart

http://www.w3.org/2001/XMLSchema#string

David M Pariser

http://www.w3.org/2001/XMLSchema#string

Michael T Jarratt

http://www.w3.org/2001/XMLSchema#string

Nicholas J Lowe

http://www.w3.org/2001/XMLSchema#string

Paul S Yamauchi

http://www.w3.org/2001/XMLSchema#string

Robert J Pariser

http://www.w3.org/2001/XMLSchema#string

P304

227-232

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1067/MJD.2003.49

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

48

http://www.w3.org/2001/XMLSchema#string

P577

2003-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12582393

http://www.w3.org/2001/XMLSchema#string